Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. - Wikidata - awgldk - TriplyDB

Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.

Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.

http://www.wikidata.org/entity/Q36579405

about

Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy The in vivo therapeutic efficacy of the oncolytic adenovirus Delta24-RGD is mediated by tumor-specific immunity Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis.Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy.Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer.Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.Tanapoxvirus lacking a neuregulin-like gene regresses human melanoma tumors in nude mice.Oncolytic Immunotherapy for Treatment of Cancer.Amalgamating oncolytic viruses to enhance their safety, consolidate their killing mechanisms, and accelerate their spread Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Tumor Restrictions to Oncolytic Virus.APOBEC3 Mediates Resistance to Oncolytic Viral Therapy

P2860

Q28083766-00D06DEE-BEFE-4BE9-92CE-005504C084C1 Q33670728-3133DE04-1A11-4823-A053-42CD2F1090ED Q35861186-87966864-6F9B-4F2E-AF19-D9F65501B1E6 Q36751597-7F0C5E48-4C86-4A05-97B2-91B4756AE3F7 Q36911654-9AA0D419-E1A4-4898-A002-B825FBF2723A Q37292354-7E0B5A2D-DC8D-48B1-9195-626BAEABE0C4 Q37325067-A7F55172-966E-4DCA-84BE-00AF600C0C79 Q37625385-0AFAD8FF-AE6C-43A8-93EA-8EDF5B831AE8 Q37646792-265AAC77-1C00-42D0-ACAE-3B6092369BEE Q38741265-63B299BF-E4CE-4B99-AE57-0C3E99211D2B Q38848223-08C47A3C-401D-4A0A-904C-319CE26913B1 Q39127778-83E3C076-0E34-4A7F-9430-E85945A7079C Q45324769-D6B13B5F-EE6E-4CAD-B4EA-9E607556E7C5 Q51846287-842AB3EB-F3BD-4981-B1B9-367982416BFD Q57192791-7D23800F-F1E5-4A62-8553-87AA799896C5

P2860

Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus.

http://www.wikidata.org/entity/Q36579405

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@ast

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@en

type

label

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@ast

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@en

prefLabel

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@ast

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@en

P1433

Q36579405-99E29BFE-ABB3-479A-99EE-AD716FAA5F75

P1476

Q36579405-DE81115F-9D11-4183-887E-4471ABD86795

P2093

Q36579405-052DD208-1D43-4C04-B6E2-EB2A94E7469A

Q36579405-124299EC-C239-493F-85E6-3B2E2548AFF4

Q36579405-39C13FC1-347A-4D98-A932-BDCF4FA63EE2

Q36579405-61078621-C457-4688-8BC7-C4766E1B4D11

Q36579405-B123DE22-FEF9-4ECC-AE37-B76766111215

Q36579405-DA550B2D-DD59-439B-8218-FA6CF36301B5

P2860

Q36579405-07696FE4-2BFC-4CD0-B1AF-1E408A954A9B

Q36579405-16B0D5C8-26FB-4999-BB34-5730B070195F

Q36579405-1C23A1FA-29CB-4BF3-97DB-F9A9E0DEFBF9

Q36579405-30C8E2EF-8384-4629-8418-D4F52EE90BA2

Q36579405-3477FEE9-C9C5-4DD3-8EFC-C3496BD8AC1E

Q36579405-3A754C34-B8ED-41C9-930A-197FD775471F

Q36579405-441C1C9D-F512-4C1A-B612-9456DA8783C0

Q36579405-503B7315-5544-4567-9F60-C9A891CA5022

Q36579405-587848BA-9FA5-4F77-B60C-A59027A33C0D

Q36579405-66D13A5D-DAFC-400B-956F-DC2AF554EF36

P304

Q36579405-B8DF32D8-D9AE-456F-8EA7-4A7DE0382CD2

P31

Q36579405-73BD13E2-4775-492B-9C26-5F113C399922

P356

Q36579405-32CB623D-B22E-446A-A2BE-DF5CDA39328B

P407

Q36579405-9FBE5ED7-24E0-416E-80E0-9DD88E66EF11

P433

Q36579405-9C75DB07-DC95-4F3E-A4DE-6E4DA4E2859A

P478

Q36579405-F0857FFB-20BE-450A-BE27-4B8CA65BD3B8

P577

Q36579405-19B10BFB-95A4-4756-B41E-6F55CA8851EB

P698

Q36579405-4DABAEAB-8380-433E-9519-27BA38ADB485

P921

Q36579405-54308F26-DE30-456A-82D6-33D04329CE44

P932

Q36579405-F8D1FD0B-0BEE-4CE1-8746-CA7C9C8353FC

P356

J.SURG.2012.09.003

P1433

P1476

Variation in susceptibility of ...... ic vesicular stomatitis virus.

@en

P2093

Aaron U Blackham

http://www.w3.org/2001/XMLSchema#string

Douglas S Lyles

http://www.w3.org/2001/XMLSchema#string

John H Stewart

http://www.w3.org/2001/XMLSchema#string

Mark Willingham

http://www.w3.org/2001/XMLSchema#string

Ralph B D'Agostino

http://www.w3.org/2001/XMLSchema#string

Scott A Northrup

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Cancer statistics, 2010

Ipilimumab plus dacarbazine for previously untreated metastatic melanoma

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Resistance to IFN-alpha-induced apoptosis is linked to a loss of STAT2

Matrix protein and another viral component contribute to induction of apoptosis in cells infected with vesicular stomatitis virus.

Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model.

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents.

The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.

P304

333-343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SURG.2012.09.003

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23102637

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3561511

http://www.w3.org/2001/XMLSchema#string